This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Cti S.a.. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: The Innovative Contributions of Eduardo Cafferata
Introduction
Eduardo Cafferata is a notable inventor based in Buenos Aires, Argentina. He has made significant strides in the field of cancer treatment through his innovative work. His contributions focus on the development of a pharmaceutical kit that combines gene therapy with chemotherapeutic agents.
Latest Patents
Cafferata holds a patent for a pharmaceutical kit and method for treating cancer. This invention is particularly relevant to the field of cancer treatment, specifically gene therapy in conjunction with a suitable chemotherapeutic agent. The patent describes a new oncolytic virus that can inhibit the growth of malignant tumors and treat hyperproliferative mammalian cells. The oncolytic virus is designed to work effectively with a chemotherapeutic agent, providing a comprehensive approach to cancer treatment. The pharmaceutical kit comprises an oncolytic adenovirus and a chemotherapeutic agent, offering a novel method for cancer therapy.
Career Highlights
Cafferata's career is marked by his dedication to advancing medical science, particularly in oncology. His innovative approach to cancer treatment has the potential to improve patient outcomes significantly. He is associated with Cti S.A., where he continues to contribute to research and development in the pharmaceutical field.
Collaborations
Throughout his career, Cafferata has collaborated with esteemed colleagues such as Osvaldo Podhajcer and Helga Weber. These collaborations have enriched his research and have been instrumental in the development of his innovative cancer treatment methods.
Conclusion
Eduardo Cafferata's work exemplifies the impact of innovation in the medical field, particularly in cancer treatment. His patented pharmaceutical kit represents a significant advancement in the fight against cancer, showcasing the importance of combining gene therapy with traditional treatments. His contributions continue to inspire future research and development in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile